2011
DOI: 10.1016/j.chemosphere.2011.08.019
|View full text |Cite
|
Sign up to set email alerts
|

Multivariate toxicity profiles and QSAR modeling of non-dioxin-like PCBs – An investigation of in vitro screening data from ultra-pure congeners

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
25
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
5
3

Relationship

2
6

Authors

Journals

citations
Cited by 30 publications
(25 citation statements)
references
References 31 publications
0
25
0
Order By: Relevance
“…Substituted positions 2,2′ were not sufficient for proving the antagonistic activity towards AhR (inactive PCBs 19,51,53,95,100,101,104,136). Stenberg et al (2011) clustered a set of 21 PCB congeners, based on their toxicity profiles from 17 different in vitro bioassays. One group included PCBs 19,74,118,122,128,138,153,168,170,180,and 190, in which effects were linked to competition with thyroid hormone thyroxine for binding to the plasma transport protein transthyretin, and anti-AhR and anti-estrogenic activities.…”
Section: Resultsmentioning
confidence: 99%
“…Substituted positions 2,2′ were not sufficient for proving the antagonistic activity towards AhR (inactive PCBs 19,51,53,95,100,101,104,136). Stenberg et al (2011) clustered a set of 21 PCB congeners, based on their toxicity profiles from 17 different in vitro bioassays. One group included PCBs 19,74,118,122,128,138,153,168,170,180,and 190, in which effects were linked to competition with thyroid hormone thyroxine for binding to the plasma transport protein transthyretin, and anti-AhR and anti-estrogenic activities.…”
Section: Resultsmentioning
confidence: 99%
“…Whereas still in its infancy, the NEQ faces several challenges before establishment in risk assessment. First, numerous modes of neurotoxicity have been documented (see "Introduction" section), often displaying different SAR requirements (eg, current work and Stenberg et al, 2011), and the question arises regarding what modes and how many modes should be included to establish an NEQ. To date the RyR is the most sensitive target of NDL PCBs and has been included in the development of NEQ schemes (Rayne and Forest, 2010;Simon et al, 2007).…”
Section: Resultsmentioning
confidence: 99%
“…Numerous modes of action have been described that may contribute to neurotoxicity. This includes altered neurotransmitter signaling (Fonnum and Mariussen, 2009;Mariussen and Fonnum, 2001;Wigestrand et al, 2013), altered GABA A receptor activity (Fernandes et al, 2010), altered Ca 2þ homeostasis through several mechanisms (Choi et al, 2016;Gafni et al, 2004;Kodavanti and Tilson, 1997;Pessah et al, 2010;Westerink, 2014), induced reactive oxygen species (Stenberg et al, 2011), altered cell viability (Dickerson et al, 2009), and alterations of neuro/endocrine processes (Bell, 2014;Fonnum and Mariussen, 2009;Kodavanti and Curras-Collazo, 2010). Of the modes identified, a particularly sensitive endpoint is the ability of NDL PCBs to enhance the activity of ryanodine sensitive Ca 2þ channels embedded in the sarco/endoplasmic reticulum (SR/ER), namely, the ryanodine receptor (RyR), in both mammals (Pessah et al, 2006) and fish (Fritsch and Pessah, 2013).…”
mentioning
confidence: 99%
“…Even if ndl-PCBs are less toxic than dl-PCBs, it could be considered that they also present a high risk level because of their complex spectrum of adverse effects and their presence as mixtures at higher concentrations in biotic and abiotic matrices (Brunelli et al, 2012;Ferrante et al, 2011;Stenberg et al, 2011). Mixtures of ndl-PCBs are generally assessed on the basis of the six so-called indicator PCBs 52,101,138,153,180) which accounted for approximately 50% of all PCB congeners present in foodstuff (EFSA, 2005).…”
Section: Risk Assessment Of Pahs and Pcbs In Tgrmentioning
confidence: 99%